Journey Medical (DERM) Total Debt (2020 - 2026)

Journey Medical has reported Total Debt for 7 years, with the latest figure at $25.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 1.57% year-over-year to $25.4 million; the trailing twelve-month figure through Mar 2026 stood at $25.4 million (up 1.57% YoY), and the FY2025 full-year result was $25.3 million, up 1.6% from the prior year.
• Total Debt for Q1 2026 stood at $25.4 million, roughly flat from $25.3 million in the prior quarter.
• The five-year high for Total Debt was $25.4 million in Q1 2026, with the low at $9.9 million in Q2 2023.
• Historically, Total Debt has averaged $20.1 million across 5 years, with a median of $19.8 million in 2022.
• Annual changes were most pronounced in 2022 — Total Debt jumped 2704.68% — and 2023, when it sank 35.8%.
• Journey Medical's Total Debt stood at $22.8 million in 2022, then slumped by 35.8% to $14.6 million in 2023, then soared by 70.15% to $24.9 million in 2024, then rose by 1.6% to $25.3 million in 2025, then advanced by 0.38% to $25.4 million in 2026.
• The last three Total Debt figures came in at $25.4 million (Q1 2026), $25.3 million (Q4 2025), and $25.2 million (Q3 2025), per Business Quant data.